Dr. Gaudreau completed his internal medicine, hematology and medical oncology fellowships at the University of Montreal. Following his clinical training, he completed a PhD program at the MD Anderson Cancer Center in Texas as well as the CHUM Research Center in Montreal, which featured both fundamental sciences and early phase clinical  trials. He has since joined the Canadian Cancer Trials Group as a Senior Investigator within the Investigational New Drug Program and Queen's Department of Oncology. He also works as a Medical Oncologist at the Cancer Centre of Southeastern Ontario. His research interests include early-phase clinical trials, investigational new drugs, tumor drug resistance, mechanisms of resistance to immunotherapy, novel immunotherapy combination strategies, and lung cancer.